跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AUROVERTIN B
首页
药物
AUROVERTIN B
Experimental
Small Molecule
AUROVERTIN B
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
25
H
32
O
8
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHOD OF TREATING CANCER USING ATP SYNTHASE INHIBITORS
US 2010190845 A1
申请人: UNIV NAT TAIWAN
优先权: 2009
US
Application of Aurovertin B in preparing drugs for preventing or treating tumor cell migration
CN 108853091 A
申请人: UNIV ZHEJIANG TECHNOLOGY
优先权: 2018
CN
一种aurovertin B衍生物及制备方法与应用
CN 111662303 B
申请人: 丽水职业技术学院
优先权: 2020
CN
Aurovertin B衍生物及其制备方法与应用
CN 112094278 B
申请人: 浙江工业大学
优先权: 2020
CN
Combined pharmaceutical composition for inhibiting triple-negative breast cancer and application thereof
CN 115154463 A
申请人: UNIV ZHEJIANG TECHNOLOGY
优先权: 2022
CN
Aurovertin B derivative as well as preparation method and application thereof
CN 116041362 A
申请人: UNIV ZHEJIANG TECHNOLOGY
优先权: 2022
CN
Camphor compound containing 1, 3, 4-thiadiazole structure as well as preparation method and application thereof
CN 121974868 A
申请人: UNIV ZHEJIANG TECHNOLOGY
优先权: 2026
CN
药物
反馈